Yeni İlaç ve Hammaddeleri Overview

  • Founded
  • 1927
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 300
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Yeni İlaç ve Hammaddeleri General Information

Description

Manufacturer and marketer of proprietary and licensed drugs. The company's' proprietary and licensed drugs are used for the treatment of hypertension in the cardiovascular area, enabling people to get rid of diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Dogan Arasli Caddesi No. 219
  • Esenyurt
  • 34850 Istanbul
  • Turkey
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Yeni İlaç ve Hammaddeleri Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yeni İlaç ve Hammaddeleri‘s full profile, request access.

Request a free trial

Yeni İlaç ve Hammaddeleri Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial